Novavax (NVAX) Tops Q1 EPS by 1c; Offers Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.88 +3.74%
Revenue Growth %: -78.2%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -78.2%
Financial Fact:
Interest income: 554K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($3.41), $0.01 better than the analyst estimate of ($3.42). Revenue for the quarter came in at $81 million versus the consensus estimate of $95.61 million.
GUIDANCE:
Novavax sees FY2023 revenue of $1400-1600 million, versus the consensus of $831.06 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
